Intuitive Surgical SVP Sells $2.7M in Stock via 10b5-1 Plan
INTUITIVE SURGICAL INC
Subscribe to track ISRG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Intuitive Surgical SVP Sells $2.7M in Stock via 10b5-1 Plan
Company: INTUITIVE SURGICAL INC (ISRG) Form: 4 | Filed: 2025-12-15 Significance: Low
Insider: Brosius Mark Title: SVP & Chief Mfg and Supply Cha | Relationship: Officer
Transaction: • Type: Option Exercise & Sell • Shares Sold: 4,964 • Avg Sale Price: ~$547.46 • Total Value: ~$2,717,580 • Owned After: 443 shares
Key Insight: This was a pre-planned sale under a Rule 10b5-1 plan. The insider exercised stock options and immediately sold the acquired shares, a common practice for liquidity and diversification.
Market Context: The total sale represents less than 0.002% of ISRG's $194.8B market capitalization, making it immaterial to the company's overall valuation.
Comprehensive Analysis
SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer conducted a routine, pre-planned sale of stock following an option exercise, as disclosed under a Rule 10b5-1 trading plan.
- Market Impact: Neutral. The transaction is immaterial relative to the company's market capitalization and public float.
Company Information
| Field | Value |
|---|---|
| Company | INTUITIVE SURGICAL INC |
| Ticker Symbol | ISRG |
| CIK | 0001035267 |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Insider Information
| Field | Value |
|---|---|
| Name | Brosius Mark |
| CIK | 0002010300 |
| Title/Position | SVP & Chief Mfg and Supply Cha |
| Relationship | Officer |
Transaction Details
This filing reports an option exercise followed by immediate sales of the acquired stock. The primary events are:
- Option Exercise (Code M): Acquired 4,500 shares at $79.6378 per share.
- Sale 1 (Code S): Sold 4,500 shares at $547.36 per share.
- Sale 2 (Code S): Sold 464 shares at $548.49 per share.
| Field | Aggregate Sale Value |
|---|---|
| Form Type | 4 |
| Transaction Dates | 2025-12-12, 2025-12-15 |
| Transaction Code | M, S |
| Security Type | Common Stock |
| Total Shares Sold | 4,964 |
| Total Sale Value | $2,717,580 |
| Shares Owned After | 443 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Total Transaction Value (Sale) | $2,717,580 |
| % of Market Cap | 0.0014% |
| Total Shares Transacted (Sale) | 4,964 |
| % of Shares Outstanding | 0.0014% |
| Post-Transaction Ownership | 443 shares (0.00012% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company with a market capitalization of $194.8 billion, a $2.7 million transaction is financially insignificant and considered routine portfolio management by an executive.
- Ownership Concentration: The insider's final holding of 443 shares is a negligible portion of the total shares outstanding, indicating very low ownership concentration.
- Transaction Significance: The sale represents a tiny fraction of both the company's market value and public float. The sale of over 90% of the shares acquired via option exercise is a common pattern for insiders to realize profits and cover exercise costs and taxes.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction was executed under a pre-disclosed Rule 10b5-1 trading plan, which severs the link between the sale and any new, non-public information. The size of the sale is immaterial.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to impact trading volume for a highly liquid stock like ISRG.
- Sentiment Indicator: Neutral. Pre-planned sales by executives are not typically viewed as a bearish signal by the market.
Additional Context
Special Circumstances
- The filing explicitly states the transactions were made pursuant to a Rule 10b5-1 trading plan. This indicates the sales were pre-scheduled and not a spontaneous decision based on recent company performance or outlook.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
